Frédérique Beau-Salinas, Annie Pierre Jonville-Béra, Haware Cissoko, Lamiae Bensouda-Grimaldi, Elisabeth Autret-Leca
INTRODUCTION: The aim of this case/non-case study was to assess and compare the risk of drug dependence associated with different migraine-specific drugs, i.e., ergot derivatives and triptans, using the French pharmacovigilance database. METHODS: Reports on drug side effects recorded in this database between January 1985 and June 2007 were analyzed, and triptans (almotriptan, eletriptan, naratriptan, sumatriptan, and zolmitriptan) as well as ergot derivatives used in acute migraine were examined...
April 2010: European Journal of Clinical Pharmacology